Increasing Breast and Colorectal Cancer Screening in the Community (NCT07748377)
A Pilot Trial of a Community-Based Strategy to Improve Colorectal and Breast Cancer Screening
🩺 Plain-English Summary (8th-Grade Level)
The goal of the proposed study is to conduct a pilot randomized controlled trial (RCT) of Chi gung, a community-based intervention using peer education and tailored navigation to simultaneously improve colorectal (CRC) and breast cancer (BC) screening rates.
Who can join: Review the eligibility criteria below.
Location: Henry Street Settlement — New York, New York
Age range: 45 Years to 75 Years
🧪 Interventions in This Study
- Chi gung: Stay Well, Live Well (BEHAVIORAL)
- Chi gung: Stay Well, Live Well (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Henry Street Settlement — New York, New York
- University Settlement — New York, New York
- Charles B. Wang Community Health Center — New York, New York
- VNS Health Chinatown Community Center — New York, New York
- The Icahn School of Medicine at Mount Sinai — New York, New York
- St. Margaret's House — New York, New York
- United Chinese Association of Brooklyn — New York, New York
📞 Contact the Study Coordinator
Phone: (216) 702-0789
Email: Christina.Wang@mountsinai.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Neoplasms
- S0820, Adenoma and Second Primary Prevention Trial — Birmingham, Alabama
- MyGI Diet for Colorectal Cancer Prevention — Ann Arbor, Michigan
- A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer — Gilbert, Arizona
- Combination Immunotherapy in Colorectal Cancer — Brooklyn, New York
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors — Encinitas, California
- Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... — Bethesda, Maryland
Explore by condition: All Colorectal Neoplasms clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.